DF
MDT icon

DecisionPoint Financial’s Medtronic MDT Stock Holding History

DecisionPoint Financial’s Portfolio MDT Stock Details MDT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$17.4K Sell
220
-8
-4% -$645 ﹤0.01% 168
2026
Q1 		$19.8K Hold
228
– – ﹤0.01% 147
2025
Q4 		$21.9K Buy
228
+212
+1,325% +$20.6K ﹤0.01% 131
2025
Q3 		$1.52K Hold
16
– – ﹤0.01% 269
2025
Q2 		$1.42K Buy
+16
New +$1.36K ﹤0.01% 263

Other funds holding MDT

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return

DecisionPoint Financial's MDT Position: Q2 2026 in Review

DecisionPoint Financial reduced its Medtronic (MDT) stake by 3.5% in Q2 2026, selling an estimated $645 and leaving 220 shares worth $17.4K. The position accounts for ﹤0.01% of the portfolio, ranked #168.

DecisionPoint Financial first reported a position in MDT in Q2 2025 and has held it in 5 quarters since. The position peaked at $21.9K in Q4 2025. 2,138 funds tracked by Wall St. Rank hold MDT as of Q2 2026.

  • DecisionPoint Financial held 220 shares of Medtronic worth $17.4K as of Q2 2026.
  • DecisionPoint Financial sold 8 Medtronic shares in Q2 2026, an estimated $645.
  • Medtronic made up ﹤0.01% of DecisionPoint Financial's portfolio in Q2 2026, its #168 holding.
  • DecisionPoint Financial first reported a position in Medtronic in Q2 2025 and has held it in 5 quarters since.
  • DecisionPoint Financial's Medtronic position peaked at $21.9K in Q4 2025.
  • 2,138 funds tracked by Wall St. Rank held Medtronic as of Q2 2026.

Based on DecisionPoint Financial's 13F filing for Q2 2026, filed 5 Aug 2026.